Abstract
Ntenga syndrome, is one of the highly epileptogenic, non-metabolic craniopathy whose aetiology is not yet known. This syndrome makes a differential diagnosis with that of Morgagni-Stewart-Morel which is rare and / or rarely mentioned in current clinical practice (entity made of frontal hyperostosis, neuropsychiatric and endocrine disorders). We report here a 58 years old female patient from Lubumbashi/ Democratic republic of Congo, followed for several years for multiform seizures, in whom the explorations of a status epilepticus, made possible to set up a new syndromic entity, called Ntenga syndrome made of a symptomatic triad (persistent multiform epileptic seizures, absence of endocrine disorder, hyperostosis frontalis interna). To date, a therapeutic protocol made of valproic acid and levetiracetam has significantly reduced to one seizure per month or even every 2 months. I think it is not without interest to report a very rare and / or new entity in the clinic
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
